• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    PEP-Therapy gets Orphan Drug Designation for Pancreatic Cancer

    GLOBENEWSWIRE

    PEP-Therapy, Curie: First Patients Dosed With PEP-010 in Ovarian

    GLOBENEWSWIRE

    PEP-Therapy, Institut Curie begins patient dosing in phase I trial of PEP-010

    PHARMABIZ

    PEP-Therapy extends Series-A financing

    PR NEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.